Daphne Quimi
CIK 1543031 · Chief Financial Officer · last filed 2026-06-12
Daphne Quimi is a Chief Financial Officer who has filed 62 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for IPSC, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $64.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$64.0K
3
62
-$1.58M
Holdings By Company
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2026-06-08 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2024-09-16 | IPSC | Buy (P) | +5,000 | $7.7K | EDGAR |
| 2024-06-21 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2024-05-16 | AMLX | Buy (P) | +5,000 | $9.4K | EDGAR |
| 2023-09-12 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −9,709 | -$129.0K | EDGAR |
| 2023-09-11 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −2,125 | -$26.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.